Cargando…
Bi-level Nasal Positive Airway Pressure (BiPAP) versus Nasal Continuous Positive Airway Pressure (CPAP) for Preterm Infants with Birth Weight Less Than 1500 g and Respiratory Distress Syndrome Following INSURE Treatment: A Two-center Randomized Controlled Trial
The present study aimed to examine the effectiveness of bi-level positive airway pressure (BiPAP) versus continuous positive airway pressure (CPAP) in preterm infants with birth weight less than 1500 g and respiratory distress syndrome (RDS) following intubation-surfactant-extubation (INSURE) treatm...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Huazhong University of Science and Technology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8204729/ https://www.ncbi.nlm.nih.gov/pubmed/34129204 http://dx.doi.org/10.1007/s11596-021-2372-8 |
_version_ | 1783708385386954752 |
---|---|
author | Pan, Rui Chen, Gao-yan Wang, Jing Zhou, Zhao-xian Zhang, Ping-ying Chang, Li-wen Rong, Zhi-hui |
author_facet | Pan, Rui Chen, Gao-yan Wang, Jing Zhou, Zhao-xian Zhang, Ping-ying Chang, Li-wen Rong, Zhi-hui |
author_sort | Pan, Rui |
collection | PubMed |
description | The present study aimed to examine the effectiveness of bi-level positive airway pressure (BiPAP) versus continuous positive airway pressure (CPAP) in preterm infants with birth weight less than 1500 g and respiratory distress syndrome (RDS) following intubation-surfactant-extubation (INSURE) treatment. A two-center randomized control trial was performed. The primary outcome was the reintubation rate of infants within 72 h of age after INSURE. Secondary outcomes included bronchopulmonary dysplasia (BPD), necrotizing enterocolitis (NEC), retinopathy of prematurity (ROP) and incidences of adverse events. Lung function at one year of corrected age was also compared between the two groups. There were 140 cases in the CPAP group and 144 in the BiPAP group. After INSURE, the reintubation rates of infants within 72 h of age were 15% and 11.1% in the CPAP group and the BiPAP group, respectively (P>0.05). Neonates in the BiPAP group was on positive airway pressure (PAP) therapy three days less than in the CPAP group (12.6 d and 15.3 d, respectively, P<0.05), and on oxygen six days less than in the CPAP group (20.6 d and 26.9 d, respectively, P<0.05). Other outcomes such as BPD, NEC, ROP and feeding intolerance were not significantly different between the two groups (P>0.05). There was no difference in lung function at one year of age between the two groups (P>0.05). In conclusion, after INSURE, the reintubation rate of infants within 72 h of age was comparable between the BiPAP group and the CPAP group. BiPAP was superior to CPAP in terms of shorter durations (days) on PAP support and oxygen supplementation. There were no differences in the incidences of BPD and ROP, and lung function at one year of age between the two ventilation methods. |
format | Online Article Text |
id | pubmed-8204729 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Huazhong University of Science and Technology |
record_format | MEDLINE/PubMed |
spelling | pubmed-82047292021-06-15 Bi-level Nasal Positive Airway Pressure (BiPAP) versus Nasal Continuous Positive Airway Pressure (CPAP) for Preterm Infants with Birth Weight Less Than 1500 g and Respiratory Distress Syndrome Following INSURE Treatment: A Two-center Randomized Controlled Trial Pan, Rui Chen, Gao-yan Wang, Jing Zhou, Zhao-xian Zhang, Ping-ying Chang, Li-wen Rong, Zhi-hui Curr Med Sci Article The present study aimed to examine the effectiveness of bi-level positive airway pressure (BiPAP) versus continuous positive airway pressure (CPAP) in preterm infants with birth weight less than 1500 g and respiratory distress syndrome (RDS) following intubation-surfactant-extubation (INSURE) treatment. A two-center randomized control trial was performed. The primary outcome was the reintubation rate of infants within 72 h of age after INSURE. Secondary outcomes included bronchopulmonary dysplasia (BPD), necrotizing enterocolitis (NEC), retinopathy of prematurity (ROP) and incidences of adverse events. Lung function at one year of corrected age was also compared between the two groups. There were 140 cases in the CPAP group and 144 in the BiPAP group. After INSURE, the reintubation rates of infants within 72 h of age were 15% and 11.1% in the CPAP group and the BiPAP group, respectively (P>0.05). Neonates in the BiPAP group was on positive airway pressure (PAP) therapy three days less than in the CPAP group (12.6 d and 15.3 d, respectively, P<0.05), and on oxygen six days less than in the CPAP group (20.6 d and 26.9 d, respectively, P<0.05). Other outcomes such as BPD, NEC, ROP and feeding intolerance were not significantly different between the two groups (P>0.05). There was no difference in lung function at one year of age between the two groups (P>0.05). In conclusion, after INSURE, the reintubation rate of infants within 72 h of age was comparable between the BiPAP group and the CPAP group. BiPAP was superior to CPAP in terms of shorter durations (days) on PAP support and oxygen supplementation. There were no differences in the incidences of BPD and ROP, and lung function at one year of age between the two ventilation methods. Huazhong University of Science and Technology 2021-06-15 2021 /pmc/articles/PMC8204729/ /pubmed/34129204 http://dx.doi.org/10.1007/s11596-021-2372-8 Text en © Huazhong University of Science and Technology 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Article Pan, Rui Chen, Gao-yan Wang, Jing Zhou, Zhao-xian Zhang, Ping-ying Chang, Li-wen Rong, Zhi-hui Bi-level Nasal Positive Airway Pressure (BiPAP) versus Nasal Continuous Positive Airway Pressure (CPAP) for Preterm Infants with Birth Weight Less Than 1500 g and Respiratory Distress Syndrome Following INSURE Treatment: A Two-center Randomized Controlled Trial |
title | Bi-level Nasal Positive Airway Pressure (BiPAP) versus Nasal Continuous Positive Airway Pressure (CPAP) for Preterm Infants with Birth Weight Less Than 1500 g and Respiratory Distress Syndrome Following INSURE Treatment: A Two-center Randomized Controlled Trial |
title_full | Bi-level Nasal Positive Airway Pressure (BiPAP) versus Nasal Continuous Positive Airway Pressure (CPAP) for Preterm Infants with Birth Weight Less Than 1500 g and Respiratory Distress Syndrome Following INSURE Treatment: A Two-center Randomized Controlled Trial |
title_fullStr | Bi-level Nasal Positive Airway Pressure (BiPAP) versus Nasal Continuous Positive Airway Pressure (CPAP) for Preterm Infants with Birth Weight Less Than 1500 g and Respiratory Distress Syndrome Following INSURE Treatment: A Two-center Randomized Controlled Trial |
title_full_unstemmed | Bi-level Nasal Positive Airway Pressure (BiPAP) versus Nasal Continuous Positive Airway Pressure (CPAP) for Preterm Infants with Birth Weight Less Than 1500 g and Respiratory Distress Syndrome Following INSURE Treatment: A Two-center Randomized Controlled Trial |
title_short | Bi-level Nasal Positive Airway Pressure (BiPAP) versus Nasal Continuous Positive Airway Pressure (CPAP) for Preterm Infants with Birth Weight Less Than 1500 g and Respiratory Distress Syndrome Following INSURE Treatment: A Two-center Randomized Controlled Trial |
title_sort | bi-level nasal positive airway pressure (bipap) versus nasal continuous positive airway pressure (cpap) for preterm infants with birth weight less than 1500 g and respiratory distress syndrome following insure treatment: a two-center randomized controlled trial |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8204729/ https://www.ncbi.nlm.nih.gov/pubmed/34129204 http://dx.doi.org/10.1007/s11596-021-2372-8 |
work_keys_str_mv | AT panrui bilevelnasalpositiveairwaypressurebipapversusnasalcontinuouspositiveairwaypressurecpapforpreterminfantswithbirthweightlessthan1500gandrespiratorydistresssyndromefollowinginsuretreatmentatwocenterrandomizedcontrolledtrial AT chengaoyan bilevelnasalpositiveairwaypressurebipapversusnasalcontinuouspositiveairwaypressurecpapforpreterminfantswithbirthweightlessthan1500gandrespiratorydistresssyndromefollowinginsuretreatmentatwocenterrandomizedcontrolledtrial AT wangjing bilevelnasalpositiveairwaypressurebipapversusnasalcontinuouspositiveairwaypressurecpapforpreterminfantswithbirthweightlessthan1500gandrespiratorydistresssyndromefollowinginsuretreatmentatwocenterrandomizedcontrolledtrial AT zhouzhaoxian bilevelnasalpositiveairwaypressurebipapversusnasalcontinuouspositiveairwaypressurecpapforpreterminfantswithbirthweightlessthan1500gandrespiratorydistresssyndromefollowinginsuretreatmentatwocenterrandomizedcontrolledtrial AT zhangpingying bilevelnasalpositiveairwaypressurebipapversusnasalcontinuouspositiveairwaypressurecpapforpreterminfantswithbirthweightlessthan1500gandrespiratorydistresssyndromefollowinginsuretreatmentatwocenterrandomizedcontrolledtrial AT changliwen bilevelnasalpositiveairwaypressurebipapversusnasalcontinuouspositiveairwaypressurecpapforpreterminfantswithbirthweightlessthan1500gandrespiratorydistresssyndromefollowinginsuretreatmentatwocenterrandomizedcontrolledtrial AT rongzhihui bilevelnasalpositiveairwaypressurebipapversusnasalcontinuouspositiveairwaypressurecpapforpreterminfantswithbirthweightlessthan1500gandrespiratorydistresssyndromefollowinginsuretreatmentatwocenterrandomizedcontrolledtrial |